home / stock / icpt / icpt short
Short Information | Intercept Pharmaceuticals Inc. (NASDAQ:ICPT)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 7,393,706 |
Total Actual Volume | 39,690,965 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 369,685 |
Average Short Percentage | 17.60% |
Is there a ICPT Short Squeeze or Breakout about to happen?
See the ICPT Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-07-2023 | $19 | $19 | $19.01 | $18.98 | 3,963,455 | 276,294 | 6.97% |
11-06-2023 | $18.97 | $18.96 | $19.02 | $18.96 | 3,612,103 | 412,584 | 11.42% |
11-03-2023 | $18.97 | $18.98 | $18.985 | $18.95 | 1,027,785 | 166,538 | 16.2% |
11-02-2023 | $18.96 | $18.98 | $18.98 | $18.93 | 2,101,181 | 860,313 | 40.94% |
11-01-2023 | $18.93 | $18.96 | $18.96 | $18.93 | 2,278,951 | 1,005,502 | 44.12% |
10-31-2023 | $18.92 | $18.93 | $18.95 | $18.92 | 1,167,064 | 89,301 | 7.65% |
10-30-2023 | $18.91 | $18.92 | $18.96 | $18.91 | 703,909 | 157,525 | 22.38% |
10-27-2023 | $18.91 | $18.91 | $18.94 | $18.9 | 873,776 | 184,118 | 21.07% |
10-26-2023 | $18.92 | $18.94 | $18.95 | $18.89 | 1,910,541 | 86,466 | 4.53% |
10-25-2023 | $18.76 | $18.82 | $18.84 | $18.76 | 655,332 | 143,894 | 21.96% |
10-24-2023 | $18.77 | $18.82 | $18.92 | $18.77 | 1,017,295 | 123,188 | 12.11% |
10-23-2023 | $18.63 | $18.82 | $18.84 | $18.63 | 724,927 | 61,571 | 8.49% |
10-20-2023 | $18.63 | $18.67 | $18.72 | $18.63 | 871,393 | 56,417 | 6.47% |
10-19-2023 | $18.63 | $18.66 | $18.68 | $18.6 | 1,033,193 | 104,049 | 10.07% |
10-18-2023 | $18.62 | $18.61 | $18.7306 | $18.6 | 1,416,791 | 478,548 | 33.78% |
10-17-2023 | $18.61 | $18.62 | $18.66 | $18.56 | 1,579,195 | 154,549 | 9.79% |
10-16-2023 | $18.55 | $18.66 | $18.68 | $18.54 | 2,713,985 | 763,517 | 28.13% |
10-13-2023 | $18.94 | $18.2 | $18.94 | $17.015 | 7,806,206 | 1,639,594 | 21% |
10-12-2023 | $18.82 | $18.95 | $18.98 | $18.78 | 3,515,578 | 565,811 | 16.09% |
10-11-2023 | $18.66 | $18.73 | $18.735 | $18.66 | 718,305 | 63,927 | 8.9% |
News, Short Squeeze, Breakout and More Instantly...
Intercept Pharmaceuticals Inc. Company Name:
ICPT Stock Symbol:
NASDAQ Market:
Intercept Pharmaceuticals Inc. Website:
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBC Precedent-setting submission includes data from post-marketing studies COBALT and Study 401 as well as real-world evidence from a claims database and patient registries FDA has assign...
Monday, Gilead Sciences Inc (NASDAQ:GILD) agreed to acquire CymaBay Therapeutics Inc (NASDAQ:CBAY) for $32.50 per share i...
Data from two Phase 2 studies in PBC show combination of OCA + bezafibrate achieved biochemical remission (normalization of ALP, total bilirubin, GGT, ALT and AST) in 40-44% of patients in the first 12 weeks OCA 5 or 5-10 mg + bezafibrate 400 mg cohorts in both studies showed a >60% ...